cro.directory
← Compare landing

Charles River Laboratories vs Syngene International

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCharles River LaboratoriesSyngene International
SummaryCharles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Services
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Microbial Fermentation
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
  • Discovery Research
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • GLP Toxicology
  • Analytical Method Development & Validation
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Cell-Line Development
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Biologics Development & Manufacturing
  • Upstream Processing
  • Downstream Processing
  • Bioanalysis
  • Peptide Manufacturing
  • Oligonucleotide Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Cell Therapy Manufacturing
  • mRNA Manufacturing
  • Translational Research
  • High-Throughput Screening
  • Genetic Toxicology
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • Carcinogenicity Studies
  • DART (Reproductive & Developmental Toxicology)
  • Specialized & Large-Animal Models
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Flow Cytometry Services
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Central Laboratory Services
  • Clinical Imaging Core Lab
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • ICH Stability Studies
  • Companion Diagnostics Development
  • Microbiology Services
  • Virology Services
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Pathology & Histology Services
  • Genomics & Sequencing Services
  • Proteomics Services
  • Bioinformatics & Data Science
  • Device & Combination Product Services
  • HPAPI Manufacturing (High-Potency)
  • Controlled Substance Manufacturing
  • Flow Chemistry & Continuous Manufacturing
  • Solid-State Chemistry & Polymorph Screening
  • Microbial Fermentation
  • ADC Payload & Linker Synthesis
  • Bioconjugation Services
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Vaccine Manufacturing
  • Microbiome / Live Biotherapeutic Manufacturing
  • Cartridge Filling
  • Lyophilization (Freeze Drying)
  • Oral Solid Dosage Manufacturing
  • Topical & Semi-Solid Manufacturing
  • Inhalation & Nasal Dosage Manufacturing
  • Ophthalmic Manufacturing
  • Technology Transfer
  • Quality Control Testing
  • Stability Testing & Storage
  • Extractables & Leachables Studies
  • Secondary Packaging & Labeling
  • Serialization & Track-and-Trace
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Peptide
  • Vaccine
Indications
  • Oncology
  • Immunology
  • Neurology
  • Oncology
  • Immunology
  • Neurology
  • Psychiatry
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Respiratory
  • Dermatology
  • Ophthalmology
  • Gastroenterology
  • Nephrology
  • Women's Health
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
  • Functional Service Provider (FSP)
Locations
  • Headquarters, United States
  • North America, North America, USA/Canada
  • Europe, Europe, Multiple
  • Asia, Asia, Multiple
  • North America, North America
  • Europe, Europe
  • Asia, Asia
  • Headquarters, Bangalore, Karnataka, India
  • U.S. Biologics Facility, United States
  • U.S. Biologics Facility, San Diego, California, United States
Certifications
  • FDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • PMDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: Retrogenix® platform data support
  • PMDA · Identifier: Retrogenix® platform data support
Data not yet provided.

Find similar companies

Charles River Laboratories alternatives · Syngene International alternatives

Markdown mirror: /compare/criver/syngeneintl.md